« Back
Home /
Imatinib-d8

Imatinib-d8

Item no.	TMO-T11640-500mg
Manufacturer	TargetMol
CASRN	1092942-82-9
Amount	500 mg
Quantity options	100 mg 10 mg 1 mg 500 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Smiles	N(C=1N=C(C=CN1)C=2C=CC=NC2)C3=CC(NC(=O)C4=CC=C(CN5C(C(N(C)C(C5([2H])[2H])([2H])[2H])([2H])[2H])([2H])[2H])C=C4)=CC=C3C
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	STI571 D8,Imatinib D8,CGP57148B D8,STI 571 D8,CGP-57148B D8
Shipping Condition	Cool pack
Available
Manufacturer - Targets	SARS-CoV\|\|\|c-Kit\|\|\|Autophagy\|\|\|PDGFR\|\|\|Bcr-Abl
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	501.65
Description	Imatinib-d8 (STI571 D8) is a 2H-labeled version of Imatinib. Imatinib is a multi-target receptor tyrosine kinase inhibitor with anti-tumor activity, selectively inhibiting BCR-ABL, v-Abl, PDGFR, c-kit kinases, and is used in chronic myeloid leukemia treatment.
Pathways	Microbiology/Virology\|\|\|Cytoskeletal Signaling\|\|\|Autophagy\|\|\|Angiogenesis\|\|\|Tyrosine Kinase/Adaptors

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T11640-500mg-datasheet.pdf

TMO-T11640-500mg-safety-datasheet.pdf